Skip to content
Open access

Exportin-5 Links miRNA Biogenesis to the Preservation of B Cell Receptor Surface Expression 2310271

Jul 2026 · Journal of Immunology · Vol 215 · 0 citations

TL;DR

Analysis revealed XPO5 depletion led to increased mutation rates specifically within the BCR light chain, implicating XPO5 in regulating the rate and fidelity of somatic hypermutation (SHM), highlighting a novel link between miRNA nuclear export machinery and the preservation of BCR integrity.

Abstract

The B cell receptor (BCR) dictates B lymphocyte identity and function, allowing for a robust adaptive immune response through antigen recognition. Strict regulation of BCR surface density dictates proper B cell signaling, immune regulation, and the prevention of malignancy, yet the factors regulating this density remain undefined. To systematically identify these regulators, we performed a genome-wide CRISPR interference (CRISPRi) screen in Ramos B cells, a human non-Hodgkin’s lymphoma cell line that undergoes constitutive somatic hypermutation (SHM) and identified Exportin-5 (XPO5) as a central regulator of BCR surface expression. We transduced dCas9-KRAB Ramos cells with a genome-wide guide RNA library and isolated BCR-positive and -negative populations by flow cytometry. Hits were validated with individual guide RNAs. Mechanisms were investigated using bulk and small RNA sequencing, and BCR mutation frequencies were quantified via the TRUST4 pipeline. XPO5 deficient cells exhibited an accelerated loss of surface BCR with no change in transcript levels, suggesting a potential post-transcriptional regulatory mechanism. Further analysis revealed XPO5 depletion led to increased mutation rates specifically within the BCR light chain, implicating XPO5 in regulating the rate and fidelity of somatic hypermutation (SHM). Transcriptomic and small RNA sequencing revealed a global reduction in miRNA levels and enrichment of target gene sets indicative of cell cycle arrest and increased DNA damage response. We identify XPO5 as a multi-faceted regulator of B cell identity. By maintaining the global miRNA landscape, XPO5 supports cell cycle progression and regulates the fidelity of somatic hypermutation. Loss of XPO5 uncouples these processes, driving light chain biased hypermutation and the loss of functional BCR surface expression. This highlights a novel link between miRNA nuclear export machinery and the preservation of BCR integrity. n/a Immune Response Regulation: Molecular Mechanisms (IRM)

Read PDF

Similar papers

Open access Aug 2026

PRMT5-mediated intron retention triggers innate and adaptive immunity against cancer

A new role for PRMT5 is defined in regulating and coordinating the interplay between the innate and adaptive immune response and it is found that RIs have a propensity to form double-stranded RNAs that contribute to the innate response.

Wiktoria Blaszczak, Wojciech Barczak, Chu-Yue Zhang et al. · 1 citation
Review Open access Sep 2026

WWP2 in immune surveillance and antigen presentation: context-dependent roles in B cells, T cells, and tumor immune escape

WWP2 is a NEDD4-family HECT E3 ubiquitin ligase with emerging relevance to immune regulation and cancer immunity. Although WWP2 has been widely studied in tumor growth, fibrosis, and cell signaling, its immune functions are less consistently integrated into current models of cancer immune surveillance. This review summ...

Wan-Chen Lu, Yi-Nan Zhu, Hai-Yan Xi et al. · 0 citations
#gene editing Open access Aug 2026

A Toolbox for Binary and Rheostat-like Modulation of TOX Expression via Genome and Epigenome Editing in Primary Human T cells

These studies show that a complete TOX knockout or silencing has no effect on exhaustion marker expression levels or the transcriptome in repeat-anti-CD3/anti-CD28-stimulated primary human T cells in vitro.

Elaine V. Schanzer, Katharine F. Vostrejs, Alexandra N. Kurciska et al. · 0 citations
Review Aug 2026

RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting

It is argued that while epitranscriptomics represents a compelling regulatory axis in cancer cell death, advancing the field will require integrative, high-resolution, and functionally precise approaches to move beyond correlative frameworks toward mechanistic and clinically actionable insights.

A. Mukherjee, Ankit Kumar Bharti, D. Mathew et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.